The table below shows ENANTA PHARMACEUTICALS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q2 2025
Q1 2025
Q4 2024
Q2 2024
Revenue
$17.16M
$18.61M
$18.31M
$14.93M
$16.96M
$17.97M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$19.44M
$20.86M
$27.21M
$28.07M
$27.66M
$28.74M
SG&A
ENTA annual revenue (10-K history)
ENANTA PHARMACEUTICALS INC reported annual revenue of $65.32M for fiscal year 2025. That is down 3.4% from $67.64M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $88.27M (FY 2016) to $65.32M. Figures come from the company's audited annual reports as filed with the SEC.